Business Wire

Prof. Stephen Wilhite Named AURAK Provost

16.7.2017 10:00 | Business Wire

Jaa

The American University of Ras Al Khaimah (AURAK) has this week announced Prof. Steven C. Wilhite as the university’s new provost and vice president for academic affairs and student success.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170716005019/en/

New AURAK Provost, Prof. Stephen Wilhite (Photo: ME NewsWire).

New AURAK Provost, Prof. Stephen Wilhite (Photo: ME NewsWire).

Prof. Wilhite, who joins the university in time for the 2017/18 academic year, brings a wealth of experience to the role. He served as provost at Widener University, Philadelphia, since 2011, as well as a period as interim president from 2015 to 2016. He also served a number of other leadership positions at Widener, such as associate provost for graduate studies, and dean of the School of Human Service Professions.

Commenting on the new appointment, AURAK president, Prof. Hassan Hamdan Al Alkim stated, “We have made significant progress over the last year, culminating in the university being granted candidacy by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC). In Prof. Wilhite, we have another outstanding administrator joining our team, who will no doubt significantly contribute to the advancement of AURAK and the attainment of our goals.”

Originally from Tennessee, Prof. Wilhite earned his bachelor’s degree in psychology from Emory University, Atlanta, U.S., where he graduated with highest honors. Upon completion of his undergraduate studies, he was awarded a Marshall Scholarship to attend the University of Oxford, England, earning a Ph.D. in Human Experimental Psychology.

Prof. Wilhite was a participant in a year-long institute for New Chief Academic Officers with the American Council on Education, attended the Management and Leadership in Education Institute at Harvard University, and had a two-year post-doctoral fellowship at the University of Illinois.

With AURAK striving for SACSCOC institutional accreditation, Prof. Wilhite also has invaluable experience. He has been a member of accreditation site visit teams for the Middle States Commission on Higher Education.

Prof. Wilhite authored the book, Learning and Memory: The Basis of Behavior (1992) and edited the book, Civic Engagement and Service Learning in a Metropolitan University: Multiple Approaches and Perspectives (2011). In total, he has more than thirty publications and has presented more than fifty scholarly papers.

Prof. Wilhite’s current research interests include applied cognitive psychology and educational psychology, especially in relation to civic and community engagement, emotional competence, higher education leadership, and faculty development.

*Source: ME NewsWire

Contact information

AURAK
Eoin Brown, +97172210900 Ext: 1325
Communications and Public Relations Department
eoin.brown@aurak.ac.ae

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme